Surprisingly, in pancreatic cancer, PP2A-B55 appears to act as an oncogene, with overexpression hyperactivating the AKT, ERK, and Wnt signaling pathways (Hein et al., 2016), indicating that the tumor suppressive role is likely tissue-specific. This evidence concerns the gene AKT1 and pancreatic neoplasm.